Valentino LA - Search Results

1

Issues complicating precision dosing for factor VIII prophylaxis.

Valentino LA, Turecek PL, Gritsch H, Butenas S, Mann KG. Valentino LA, et al. Transfus Apher Sci. 2018 Aug;57(4):472-479. doi: 10.1016/j.transci.2018.07.007. Epub 2018 Aug 21. Transfus Apher Sci. 2018. PMID: 30139569 Free article. Review.

2

The biological efficacy profile of BAX 855, a PEGylated recombinant factor VIII molecule.

Valentino LA, Cong L, Enockson C, Song X, Scheiflinger F, Muchitsch EM, Turecek PL, Hakobyan N. Valentino LA, et al. Haemophilia. 2015 Jan;21(1):58-63. doi: 10.1111/hae.12532. Epub 2014 Dec 2. Haemophilia. 2015. PMID: 25459309

3

The role of ultralarge multimers in recombinant human von Willebrand factor - a review of physico-and biochemical studies and findings in in vivo models and in humans with von Willebrand disease.

Turecek PL, Spannagl M, Kragh T, Allmaier G, Turecek M, Schrenk G, Gritsch H, Obermann-Slupetzky O, Ewenstein BM, Valentino LA. Turecek PL, et al. Among authors: valentino la. Hamostaseologie. 2017;37(S 01):S15-S25. doi: 10.5482/HAMO-17-04-0018. Epub 2017 Dec 28. Hamostaseologie. 2017. PMID: 29582921 English.

4

Experience with a third generation recombinant factor VIII concentrate (Advate) for immune tolerance induction in patients with haemophilia A.

Valentino LA, Recht M, Dipaola J, Shapiro AD, Pipe SW, Ewing N, Urgo J, Bullock T, Simmons M, Deguzman C. Valentino LA, et al. Haemophilia. 2009 May;15(3):718-26. doi: 10.1111/j.1365-2516.2008.01960.x. Epub 2009 Feb 27. Haemophilia. 2009. PMID: 19298383 Free article.

5

Multicentre, randomized, open-label study of on-demand treatment with two prophylaxis regimens of recombinant coagulation factor IX in haemophilia B subjects.

Valentino LA, Rusen L, Elezovic I, Smith LM, Korth-Bradley JM, Rendo P. Valentino LA, et al. Haemophilia. 2014 May;20(3):398-406. doi: 10.1111/hae.12344. Epub 2014 Jan 13. Haemophilia. 2014. PMID: 24418368 Clinical Trial.

6

Prophylactic bypassing agent use before and during immune tolerance induction in patients with haemophilia A and inhibitors to FVIII.

Carpenter SL, Khair K, Gringeri A, Valentino LA. Carpenter SL, et al. Among authors: valentino la. Haemophilia. 2018 Jul;24(4):570-577. doi: 10.1111/hae.13534. Epub 2018 Jun 14. Haemophilia. 2018. PMID: 29901839 Review.

7

Considerations in individualizing prophylaxis in patients with haemophilia A.

Valentino LA. Valentino LA. Haemophilia. 2014 Sep;20(5):607-15. doi: 10.1111/hae.12438. Epub 2014 Apr 8. Haemophilia. 2014. PMID: 24712891 Review.

8

A randomized comparison of two prophylaxis regimens and a paired comparison of on-demand and prophylaxis treatments in hemophilia A management.

Valentino LA, Mamonov V, Hellmann A, Quon DV, Chybicka A, Schroth P, Patrone L, Wong WY; Prophylaxis Study Group. Valentino LA, et al. J Thromb Haemost. 2012 Mar;10(3):359-67. doi: 10.1111/j.1538-7836.2011.04611.x. J Thromb Haemost. 2012. PMID: 22212248 Free PMC article. Clinical Trial.

9

Surgical experience with rFVIIa (NovoSeven) in congenital haemophilia A and B patients with inhibitors to factors VIII or IX.

Valentino LA, Cooper DL, Goldstein B. Valentino LA, et al. Haemophilia. 2011 Jul;17(4):579-89. doi: 10.1111/j.1365-2516.2010.02460.x. Epub 2011 Feb 7. Haemophilia. 2011. PMID: 21294815 Review.

10

Patient- and caregiver-reported bleeding symptoms and reasons for starting and stopping treatment with recombinant factor VIIa: analysis of the Dosing Observational Study in Haemophilia (DOSE).

Valentino LA, Walsh CE, Reding MT, Young GA, Levendoglu-Tugal O, Cooper DL. Valentino LA, et al. Haemophilia. 2012 Jul;18(4):554-60. doi: 10.1111/j.1365-2516.2012.02762.x. Epub 2012 Feb 20. Haemophilia. 2012. PMID: 22348407

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

144 results

Search Page